{
  "url": "https://openlegislation.uk/eu-regulation-2018-1556/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2018-1556/annex.json",
  "legislation": "eur/2018/1556",
  "legislation_title": "Commission Regulation (EU) 2018/1556 of 17 October 2018 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2018-1556",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": "Rejected health claim",
  "text": "Application — Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nStablor®, a drink preparation with defined macro- and micronutrient composition and specific proportion of amino acids (tryptophan to neutral amino acids ratio)\nIn the context of a well-balanced diet and a mild caloric restriction, the addition of Stablor® contributes to decrease visceral fat while preserving lean mass in overweight or obese subjects with abdominal fat and cardiometabolic risk factors.\nQ-2016-00319\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nCurcumin\nCurcumin contributes to the normal functioning of joints.\nQ-2016-00856\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nA carbohydrate:protein (CHO:P) ratio ≤ 1.8 on an energy basis in the context of an energy-restricted diet and body weight\nHelps to achieve a reduction in body weight and body fat when consumed as part of an energy restricted diet (< 8 368 kJ/2 000 kcal/day) for a minimum of 12 weeks.\nQ-2016-00436\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nVibigaba (germinated brown rice)\nIn the context of an energy-restricted diet contributes to weight loss.\nQ-2017-00032\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nVibigaba (germinated brown rice)\nContributes to the maintenance of normal blood glucose levels.\nQ-2017-00033\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nVibigaba (germinated brown rice)\nContributes to the maintenance of normal blood pressure.\nQ-2017-00031\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data\nVibigaba (germinated brown rice)\nContributes to the maintenance of normal blood cholesterol levels.\nQ-2017-00030",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2018/1556/annex",
    "retrieved_at": "2026-11-01T14:43:55.157196+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}